Bartlett & Co. LLC
- SEC CIK
- 0001550075
- Latest filing
- Jan 8, 2024
DNLI holding history
Denali Therapeutics Inc. in every 13F filed by Bartlett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNLI overviewAll 13F holders of DNLIFull Q4 2023 holdings
- Shares (Q4 2023)
- 1,500
- Value
- $33.0K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 1,500 | $33.0K | <0.1% | −23,300−94.0% | Reduced | Holders |
| Q3 2023 | 24,800 | $512.0K | <0.1% | +3,260+15.1% | Added | Holders |
| Q2 2023 | 21,540 | $636.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 21,540 | $496.0K | <0.1% | +760+3.7% | Added | Holders |
| Q4 2022 | 20,780 | $578.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 20,780 | $638.0K | <0.1% | +2,269+12.3% | Added | Holders |
| Q2 2022 | 18,511 | $545.0K | <0.1% | +10.0% | Added | Holders |
| Q1 2022 | 18,510 | $595.0K | <0.1% | +1,567+9.2% | Added | Holders |
| Q4 2021 | 16,943 | $756.0K | <0.1% | +15,443+1,029.5% | Added | Holders |
| Q3 2021 | 1,500 | $76.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,500 | $118.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 1,500 | $86.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.